For the selection of the optimal API, several solid forms may be available from one molecule. We provide an effective comparative programmethat will lead to a better orientation and targeted selection of the optimum solid form of a certain pharmaceutical molecule with requested properties.
• In vitrobioequivalence studies, which are less variable, easier to control, and can predict thein vivobioequivalence, saving time and cost
• Study of the dissolution rate profile of various forms
• Stability evaluation of various forms at different conditions of temperature and humidity
• Identification of the best physical form for pre-formulation